Eli Lilly covid-19 Coronavirus Eli Lilly

Coronavirus: Eli Lilly antibody treatment trials halted due to safety concern

Reading now: 883
globalnews.ca

COVID-19 antibody treatment has been paused because of a safety concern.“Out of an abundance of caution, the ACTIV-3 independent data safety monitoring board (DSMB) has recommended a pause in enrollment,” Lilly spokeswoman Molly McCully said in an emailed statement.“Lilly is supportive of the decision by the independent DSMB to cautiously ensure the safety of the patients participating in this study.”Lilly shares were down about three per cent at $150..

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA